Altogether, atherosclerosis studies performed under both LDAH deficiency and overexpression identify LDAH as an atheroprotective player that promotes favorable lesion remodeling by reducing necrosis and increasing fibrosis, and suggest that the mechanisms of atheroprotection involve modulation of myeloid cells. The gene discussed is LDAH; the disease is atherosclerosis.